[Effect of misoprostol, a synthetic prostaglandin E analog, on levels of serum C-peptide in serum and glucose tolerance].
The aim of the study was to investigate whether oral application of misoprostol (MI), which is an analogue of prostaglandin E1, does change the secretion of insulin and the blood glucose level. The investigations were carried out in 15 subjects, aged 21-40 yrs, with a gastric or duodenal ulcer and without any disturbances of the digestive tract motility. In 7 of them (group A), without stated diabetes a single oral dose of 400 mg MI versus placebo (PL) and 15 min later 75 g glucose p.o., was applied in randomized order, on different days, in fasting state. In 8 subjects with mild diabetes type II (gr B) MI versus PL and after 15 min. i.v. 1.0 mg glucagon was similarly administered. In both groups the concentrations of glucose and C-peptide in blood were determined. In comparison to PL, the application of MI did not cause any statistically significant differences of C-peptide in serum and blood glucose levels neither before and after oral glucose loading nor after i.v. administration of glucagon. Statistically not significant were also the differences in AUC (p > 0.05).
Jonderko
G
G
IV Katedry i Kliniki Chorób Wewnetrznych Sl. AM, Tychy.
Bednarczyk-Kałuzny
M
M
Straszecka
J
J
Krzewiński
W
W
Kucharz
E J
EJ
D000328:Adult; D001786:Blood Glucose / Q000187:drug effects* / Q000378:metabolism; D002096:C-Peptide / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy; D004381:Duodenal Ulcer / Q000188:drug therapy; D005934:Glucagon / Q000494:pharmacology; D006801:Humans; D008297:Male; D016595:Misoprostol / Q000494:pharmacology* / Q000627:therapeutic use; D011863:Radioimmunoassay; D013276:Stomach Ulcer / Q000188:drug therapy
D001786:Blood Glucose; D002096:C-Peptide; D016595:Misoprostol; D005934:Glucagon
Wpływ misoprostolu, syntetycznego odpowiednika prostaglandyny E1, na stezenie peptydu C w surowicy krwi i tolerancje glukozy.